Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today

Yahoo FinanceOct 3 17:50 ET

Eli Lilly and Co (LLY.US) explores new uses for "miracle weight-loss drug" Zepbound, aiming to reduce the incidence of diabetes and other high-risk populations.

eli lilly and co is exploring new uses for its weight loss drug Zepbound to reduce the incidence of diabetes in high-risk populations, even if they are not overweight.

Zhitong FinanceOct 2 03:57 ET

Lilly Looking to Test Zepbound as Health Maintenance Drug: Report

Seeking AlphaOct 1 10:22 ET

New Small-cap Buy and Sell Ideas for Oppenheimer's 50/50 List

Seeking AlphaSep 30 12:34 ET

Roche Sees Carmot Obesity Drugs' Potential Peak Sales at $3.6B+: Report

Seeking AlphaSep 30 11:25 ET

Morgan Stanley Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $105

Moomoo NewsSep 30 05:33 ET · Ratings